Felix C Ng1, Bruce C V Campbell2. 1. Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Grattan Street, Parkville, VIC, 3050, Australia. 2. Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Grattan Street, Parkville, VIC, 3050, Australia. bruce.campbell@mh.org.au.
Abstract
PURPOSE OF REVIEW: Urgent reperfusion treatment with intravenous thrombolysis or mechanical thrombectomy reduces disability after ischaemic stroke. Imaging plays an important role in identifying patients who benefit, particularly in extended time windows. However, the role of post-treatment neuroimaging is less well established. We review recent advances in neuroimaging after reperfusion treatment and provide a practical guide to the options and management implications. RECENT FINDINGS: Post-treatment imaging is critical to identify patients with reperfusion-related haemorrhage and oedema requiring intervention. It also can guide the timing and intensity of antithrombotic medication. The degree of reperfusion on post-thrombectomy angiography and infarct volume and topography using CT or MRI carry important prognostic significance. Perfusion-weighted MRI and permeability analysis may help detect persistent perfusion abnormalities post-treatment and predict haemorrhagic complications. Post-treatment neuroimaging provides clinically relevant information to identify complications, assess prognosis and perform quality assurance after acute ischaemic stroke. Recent advances in neuroimaging represent a potential avenue to explore post-reperfusion pathophysiology and uncover therapeutic targets for secondary ischaemic and haemorrhagic injury.
PURPOSE OF REVIEW: Urgent reperfusion treatment with intravenous thrombolysis or mechanical thrombectomy reduces disability after ischaemic stroke. Imaging plays an important role in identifying patients who benefit, particularly in extended time windows. However, the role of post-treatment neuroimaging is less well established. We review recent advances in neuroimaging after reperfusion treatment and provide a practical guide to the options and management implications. RECENT FINDINGS: Post-treatment imaging is critical to identify patients with reperfusion-related haemorrhage and oedema requiring intervention. It also can guide the timing and intensity of antithrombotic medication. The degree of reperfusion on post-thrombectomy angiography and infarct volume and topography using CT or MRI carry important prognostic significance. Perfusion-weighted MRI and permeability analysis may help detect persistent perfusion abnormalities post-treatment and predict haemorrhagic complications. Post-treatment neuroimaging provides clinically relevant information to identify complications, assess prognosis and perform quality assurance after acute ischaemic stroke. Recent advances in neuroimaging represent a potential avenue to explore post-reperfusion pathophysiology and uncover therapeutic targets for secondary ischaemic and haemorrhagic injury.
Authors: M Fiorelli; S Bastianello; R von Kummer; G J del Zoppo; V Larrue; E Lesaffre; A P Ringleb; S Lorenzano; C Manelfe; L Bozzao Journal: Stroke Date: 1999-11 Impact factor: 7.914
Authors: C S Kidwell; J L Saver; J Mattiello; S Starkman; F Vinuela; G Duckwiler; Y P Gobin; R Jahan; P Vespa; J P Villablanca; D S Liebeskind; R P Woods; J R Alger Journal: Neurology Date: 2001-12-11 Impact factor: 9.910
Authors: C Oppenheim; Y Samson; R Manaï; T Lalam; X Vandamme; S Crozier; A Srour; P Cornu; D Dormont; G Rancurel; C Marsault Journal: Stroke Date: 2000-09 Impact factor: 7.914
Authors: S E Kasner; A M Demchuk; J Berrouschot; E Schmutzhard; L Harms; P Verro; J A Chalela; R Abbur; H McGrade; I Christou; D W Krieger Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks Journal: Stroke Date: 2003-07-17 Impact factor: 7.914
Authors: Adnan I Qureshi; Amir M Siddiqui; Stanley H Kim; Ricardo A Hanel; Andrew R Xavier; Jawad F Kirmani; M Fareed K Suri; Alan S Boulos; L Nelson Hopkins Journal: AJNR Am J Neuroradiol Date: 2004-02 Impact factor: 3.825
Authors: Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger Journal: Ann Neurol Date: 2002-12 Impact factor: 10.422
Authors: Mayank Goyal; Ryan McTaggart; Johanna M Ospel; Aad van der Lugt; Michael Tymianski; Roland Wiest; Johan Lundberg; Rüdiger von Kummer; Michael D Hill; Sven Luijten; Bob Roozenbeek; Jeffrey L Saver; Rosalie V McDonough Journal: Neuroradiology Date: 2022-07-20 Impact factor: 2.995